Cargando…
Thiopurine Drugs in the Treatment of Ulcerative Colitis: Identification of a Novel Deleterious Mutation in TPMT
Chronic inflammatory bowel disease (IBD) includes Crohn’s disease and ulcerative colitis. Both are characterized by inflammation of part of the digestive tract lining. Azathioprine (AZA) is a well-known immunosuppressant that has been known for many years for its ability to provide long-term disease...
Autores principales: | Harmand, Pierre-Olivier, Solassol, Jérôme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602704/ https://www.ncbi.nlm.nih.gov/pubmed/33081236 http://dx.doi.org/10.3390/genes11101212 |
Ejemplares similares
-
Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk
por: Nguyen, Christine M., et al.
Publicado: (2011) -
The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn’s Disease
por: Ha, Changhee, et al.
Publicado: (2020) -
In Vitro Protein Stability of Two Naturally Occurring
Thiopurine S-Methyltransferase Variants: Biophysical Characterization
of TPMT*6 and TPMT*8
por: Wennerstrand, Patricia, et al.
Publicado: (2017) -
A bioinformatics approach to the identification of novel deleterious mutations of human TPMT through validated screening and molecular dynamics
por: Saxena, Sidharth, et al.
Publicado: (2022) -
A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs
por: Skrzypczak-Zielinska, Marzena, et al.
Publicado: (2016)